Seebio
Seebio is a Shanghai-based life sciences company founded in 2003 that produces and sells diagnostic reagent raw materials, including enzymes, antigens, antibodies, reference standards, and mRNA raw materials, serving IVD manufacturers, vaccine developers, and research institutions across 100+ countries through e-commerce, direct sales, and OEM custom synthesis.
- Company typePrivate
- Founded2003
- HeadquartersShanghai, China
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Seebio does
Seebio (Xibao Bio-tech (Shanghai) Joint Stock Co., Ltd.) is a Shanghai-based life sciences company founded in 2003 that produces and sells diagnostic reagent raw materials, including enzymes, antigens, antibodies, reference standards, separation and purification media, biochemical reagents, molecular biology reagents, and mRNA raw materials. The company operates seven proprietary technology platforms spanning synthetic biology, protein expression, antibody production, diagnostic reagent development, biopharmaceutical, PEG and chemical synthesis, and mRNA raw materials, supported by an Academician Expert Workstation, ISO 9001/14001/45001 certifications, and granted patents covering nanobodies and IVD device designs.
The company serves IVD manufacturers, vaccine developers, life science research institutions, and nutritional health/biopharmaceutical customers across China and over 100 countries, claiming 10,000+ customers including 600+ listed IVD and biopharma companies and 3,000+ health-sector enterprises. Distribution runs through the Seebio Mall e-commerce platform, six China-focused direct sales business departments, and international channels, with active participation in CPHI and Vitafoods Europe exhibitions.
Seebio generates revenue through unit-priced catalog sales of reagent products (one-time purchase model) and quote-based OEM/custom synthesis services spanning antibody, protein, synthetic biology, diagnostic reagent, and chemical synthesis projects. Manufacturing is anchored by its wholly-owned subsidiary Quanyangtang (Jiangsu) Biomedical, which operates a 66,000+ sqm bio-manufacturing base with 5,110 ton/year capacity for vitamin K2, HMOs, lactoferrin, and other biological core raw materials, with a 150 million yuan technical renovation expansion underway in 2026.
Seebio firmographics
Firmographics- Name
- Seebio
- Legal name
- 西宝生物科技（上海）股份有限公司
- Website
- https://seebio.cn
- Company type
- Private
- Founded year
- 2003
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Seebio is a Shanghai-based life sciences company founded in 2003 that produces and sells diagnostic reagent raw materials, including enzymes, antigens, antibodies, reference standards, and mRNA raw materials, serving IVD manufacturers, vaccine developers, and research institutions across 100+ countries through e-commerce, direct sales, and OEM custom synthesis.
- Ownership category
- akta.pro rank
Seebio industry classification
Industry- Product category
- Diagnostic reagent raw materials
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Raw Materials & Critical Reagents Supply (Media/Resins/Cytokines) (HLAGAGAI)
Keywords
Where Seebio is headquartered
LocationHeadquarters
- HQ city
- Shanghai
- HQ country
- China
- HQ region
- Asia
Offices3 records
Markets served
Seebio business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Personnel, Operations, Infrastructure, Marketing or Sales
Revenue model
- Diagnostic Reagent Raw Materials: Sale of enzymes, antibodies, antigens, standards, and biological materials for IVD and research applications
- Research Reagents: Biochemical reagents, cell culture products, molecular biology reagents, and separation/purification materials
- Custom Synthesis and OEM Services: Custom protein expression, antibody production, synthetic biology, diagnostic reagent development, biopharmaceutical, and chemical synthesis services
- Vaccine Raw Materials: Vaccine components including vaccine raw materials, cell culture products, and immune adjuvants
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Various reagent products with tiered packaging options |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
Seebio product offering
Product offeringCore offering
Seebio is a producer and seller of diagnostic reagent raw materials and life science reagents. Its core catalog covers enzymes and substrates, antigens and antibodies, reference standards/controls, biopharmaceutical and vaccine raw materials, separation and purification materials, biochemical reagents, molecular biology reagents, and mRNA raw materials, sold under the Seebio® brand and through its own e-commerce mall. Alongside catalog products, Seebio runs six custom service platforms (synthetic biology, protein expression, antibody production, diagnostic reagent development, biopharmaceutical, and chemical synthesis/PEG derivatives) delivering OEM and custom synthesis work for IVD and biopharma customers.
Product overview
Seebio (西宝生物科技（上海）股份有限公司) is a life sciences company offering a comprehensive portfolio of diagnostic reagent raw materials, scientific research reagents, and custom services. The core product portfolio spans enzyme and substrate products (酶及底物), antigens and antibodies (抗原和抗体), reference standards and controls (标准品/对照品), biopharmaceutical and vaccine materials (生物制药与疫苗), separation and purification materials (分离纯化), biochemical reagents (生化试剂), molecular biology reagents (分子生物学), and mRNA raw materials (mRNA原料). Custom/OEM services (OEM定制服务) are also provided. The company operates multiple service technology platforms including synthetic biology (合成生物学平台), protein expression (蛋白表达平台), antibody production (抗体生产平台), diagnostic reagent development (诊断试剂开发平台), biopharmaceutical (生物制药平台), and chemical synthesis (化学合成平台). Seebio also distributes internationally branded products through its Seebio Mall e-commerce platform.
Differentiator
Problem solved
Functional benefit
Products and services
- Enzymes and Substrates (酶及底物) Comprehensive enzyme product line including biochemical enzymes, labeling enzymes, natural-source enzymes, molecular diagnostic enzymes, industrial enzymes, enzyme substrates and chromogenic substrates, coenzymes, and lyophilization protectants, for IVD manufacturers and life science researchers.
- Antigens and Antibodies (抗原和抗体) Immunology products including antigens, antibodies, and cell lines spanning infectious diseases (COVID-19, coronavirus), liver/kidney function, hormones/fertility, cardiovascular markers, tumor markers, inflammation/autoimmune, metabolic syndrome, and coagulation/anemia, for IVD kit manufacturers.
- Reference Standards and Controls (标准品/对照品) Standards, reference materials, calibrators, quality controls, reference reagents, and interference substances for IVD assay development and validation.
- Biopharmaceutical and Vaccine Raw Materials (生物制药与疫苗) Vaccine raw materials, cell culture reagents, modified polyethyleneglycols, viral inactivators, immunologic adjuvants, cell transfection reagents, microbial culture media, antifoaming agents, lysing agents, and other vaccine development components for vaccine manufacturers and biopharma companies.
- Separation and Purification Materials (分离纯化) Separation materials including microspheres, magnetic beads, membranes, silica gel, and chromatography media for downstream purification applications in IVD, biopharma, and research workflows.
- Biochemical Reagents (生化试剂) General biochemical reagents including biological buffers, sugars, nucleotides and derivatives, amino acids and derivatives, protein/enzyme protectants, surfactants, denaturants, preservatives, bactericides, vitamins, antibiotics and enzyme inhibitors, and biological dyes/indicators for research and industrial customers.
- Molecular Biology Reagents (分子生物学) Molecular biology products covering nucleases and nuclease removers, sequencing reagents, biological sample preservation, RNA preservation/extraction, nucleic acid extraction/amplification/electrophoresis, enzymes, and reagent kits for molecular diagnostic manufacturers and life science researchers.
- mRNA Raw Materials (mRNA原料) Complete mRNA raw material offerings including mRNA in vitro transcription reagents, mRNA modification reagents, mRNA purification reagents, and formulation delivery systems for mRNA therapeutics developers.
- OEM Custom Services (OEM定制服务) Custom development services covering new-category testing, IVD process and formulation development, custom antibody development, custom protein expression, and novel enzyme custom development for IVD and biopharma customers.
- PEG and Derivative Technology Platform (聚乙二醇及其衍生物技术平台) Chemical synthesis platform for monodisperse polyethylene glycol, PEG hydroxy raw materials, PEGylated drugs, and PEGylated hydrogels, providing bioconjugation and purification modification services for protein, peptide, antibody, and small molecule drug developers.
- Protein Expression Platform (蛋白表达平台) Service platform for recombinant antibody development, cell technology, recombinant protein expression, and detection services for IVD and biopharma customers.
- Diagnostic Reagent Development Platform (诊断试剂开发平台) Comprehensive diagnostic reagent development platform covering protein/antibody labeling, IVD kit OEM development, antigen analysis and design, recombinant antigen expression, antibody pair screening, colloidal gold labeling and test strip development, and ELISA kit development (feasibility, optimization, validation, production).
- Seebio Mall (西宝商城) E-commerce Platform E-commerce platform at mall.seebio.cn distributing Seebio's own Seebio® brand reagents and partner-brand products including Wako, Jackson ImmunoResearch, Abcam, Sigma, and CST to global SMB and individual buyers.
Quantifiable outcome
- Serving over 10,000 customers globally
- +2 more outcomes
Companies that use Seebio
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles3 records
Seebio technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Seebio partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core and minor.
- 上海景宇生物科技有限公司coreFully acquired in 2014 to expand diagnostic reagent business
- 和记黄埔 (Hutchison Whampoa)coreStrategic partnership established in 2013 for health product development and distribution in the Chinese market
- 美国汉优集团 (US HanYou Group)coreStrategic partnership established in 2013 for health product development with American HanYou Group
- Vitamin K2 Production PartnerminorJoint venture established in 2006 for vitamin K2 series products and plant extract R&D and production
Scale indicators10 records
Recent moves10 records
Expansion highlights5 records
Seebio competitors and assessment
Company assessmentBroad incumbents
- Cytiva: Global life sciences tools and raw materials supplier (formerly GE Healthcare Life Sciences) providing bioreactor inputs, chromatography media, and bioprocessing raw materials. Overlaps with Seebio's biopharmaceutical and vaccine raw materials and separation/purification categories.
- Bio-Rad Laboratories: US-headquartered life science research and clinical diagnostics company offering a broad reagent, antibody, and IVD raw material portfolio. A global incumbent that competes across Seebio's antibody, standards, and diagnostic reagent development product lines.
- Thermo Fisher Scientific: The largest global life sciences tools company, spanning reagents, antibodies, IVD raw materials, bioprocessing inputs, and OEM services. Competes with Seebio across essentially every catalog and service category, with vastly greater scale and a global commercial footprint.
- Merck KGaA (Sigma-Aldrich): Life science division of Merck KGaA and operator of the Sigma-Aldrich brand, the most comprehensive global catalog of biochemicals, reagents, antibodies, and analytical standards. The dominant incumbent that defines pricing and quality benchmarks for Seebio's core reagent categories.
Direct peers
- ACROBiosystems: Chinese recombinant protein and reagent supplier specializing in high-quality biologics, viral proteins, and IVD raw materials. Closely comparable to Seebio's antigen, antibody, and standards catalog for diagnostic and therapeutic development customers.
- GenScript: Chinese-founded life sciences company providing gene synthesis, recombinant proteins, peptides, antibodies, and cell therapy services. Overlaps directly with Seebio's protein expression, antibody production, and custom synthesis platforms, and competes for the same IVD/biopharma customer base.
- Beijing Solarbio Science & Technology: Chinese life science reagent manufacturer with a broad catalog of biochemicals, antibodies, and cell culture products. Competes head-on with Seebio's biochemical reagent and life science research offerings, particularly for academic and biopharma customers in China.
- ABclonal Technology: Wuhan-based antibody and molecular biology reagent manufacturer offering polyclonal/monoclonal antibodies, ELISA kits, and IVD-related services. Directly overlaps Seebio's antibody production and diagnostic reagent development platforms in the Chinese life sciences market.
- Sino Biological: Beijing-headquartered recombinant protein, antibody, and reagent manufacturer serving IVD, biopharma, and research customers globally. Highly comparable to Seebio's recombinant antigen/antibody and IVD raw materials offering, with deeper scale and an established STAR Market listing.
- MedChemExpress: Global life science chemical and biochemical supplier with strong roots in the Chinese reagent ecosystem. Overlaps with Seebio's catalog biochemicals, standards, and research reagents in serving international biopharma and academic customers.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Seebio social profiles
Digital presenceSeebio compliance and trust
Trust signalCompliance7 records
Seebio financial estimates
Financial estimateRevenue estimate
Valuation estimate
Seebio leadership team
Management profileNumber of profiles
Profiles1 record
Seebio subsidiaries and ownership
Company hierarchySubsidiaries1 record
Seebio funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Seebio M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Seebio
What does Seebio do?
Seebio is a producer and seller of diagnostic reagent raw materials and life science reagents. Its core catalog covers enzymes and substrates, antigens and antibodies, reference standards/controls, biopharmaceutical and vaccine raw materials, separation and purification materials, biochemical reagents, molecular biology reagents, and mRNA raw materials, sold under the Seebio® brand and through its own e-commerce mall. Alongside catalog products, Seebio runs six custom service platforms (synthetic biology, protein expression, antibody production, diagnostic reagent development, biopharmaceutical, and chemical synthesis/PEG derivatives) delivering OEM and custom synthesis work for IVD and biopharma customers.
Is Seebio a public or private company?
Seebio is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Seebio founded?
Seebio was founded in 2003. It employs 11 to 50 people.
Where is Seebio based?
Seebio is headquartered in Shanghai, China, in the Asia region.
How does Seebio make money?
Four revenue lines are on record. Diagnostic Reagent Raw Materials are the primary driver. The others are research Reagents, custom Synthesis and OEM Services and vaccine Raw Materials.
Who are Seebio's main competitors?
Broad incumbents on record are Cytiva, Bio-Rad Laboratories, Thermo Fisher Scientific and Merck KGaA (Sigma-Aldrich). Direct peers are ACROBiosystems, GenScript, Beijing Solarbio Science & Technology, ABclonal Technology, Sino Biological and MedChemExpress.
Does Seebio have an API?
No public API is recorded for Seebio.
What industry is Seebio in?
Seebio's product category is Diagnostic reagent raw materials. Its primary akta.pro industry code is HLAGAGAI, Raw Materials & Critical Reagents Supply (Media/Resins/Cytokines). Its NAICS code is 325413 and its SIC code is 2833.